83 related articles for article (PubMed ID: 2807151)
21. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
22. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
24. Familial medullary thyroid cancer: clinical aspects and prognosis.
Hyer SL; Newbold K; Harmer C
Eur J Surg Oncol; 2005 May; 31(4):415-9. PubMed ID: 15837050
[TBL] [Abstract][Full Text] [Related]
25. Medullary thyroid carcinoma.
Leboulleux S; Baudin E; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2004 Sep; 61(3):299-310. PubMed ID: 15355445
[TBL] [Abstract][Full Text] [Related]
26. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
[TBL] [Abstract][Full Text] [Related]
27. Medullary carcinoma of the thyroid gland in Norway. Serum calcitonin in 300 relatives of 43 patients.
Normann T; Gautvik KM
Ann Chir Gynaecol; 1977; 66(4):187-94. PubMed ID: 907311
[TBL] [Abstract][Full Text] [Related]
28. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
29. [Medullary cancer of the thyroid].
Calmettes C
Bull Cancer; 1990; 77(11):1063-72. PubMed ID: 2275984
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic and flow cytometric DNA study of medullary thyroid carcinoma.
el-Naggar AK; Ordonez NG; McLemore D; Schultz P; Hickey RC; Samaan N
Surgery; 1990 Dec; 108(6):981-5. PubMed ID: 2247844
[TBL] [Abstract][Full Text] [Related]
31. [Effects of subcutaneous administration of sandostatine (SMS 201.995) in 18 cases of thyroid medullary cancer].
Modigliani E; Guliana JM; Maroni M; Guillausseau JP; Chabrier G; Dupont JL; Caron J; Roger P; Bentata Pessayre M; Jacob C
Ann Endocrinol (Paris); 1989; 50(6):483-8. PubMed ID: 2635843
[TBL] [Abstract][Full Text] [Related]
32. Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
Elisei R; Lorusso L; Piaggi P; Torregrossa L; Pellegrini G; Molinaro E; Agate L; Bottici V; Pani F; Cacciato Insilla A; Casella F; Ciampi R; Tognetti I; Materazzi G; Basolo F; Romei C
Eur J Endocrinol; 2015 Sep; 173(3):297-304. PubMed ID: 26034076
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of calcitonin immunostaining in medullary carcinoma of the thyroid.
Saad MF; Ordonez NG; Guido JJ; Samaan NA
J Clin Endocrinol Metab; 1984 Nov; 59(5):850-6. PubMed ID: 6207198
[TBL] [Abstract][Full Text] [Related]
34. Medullary carcinoma of the thyroid.
Brenner H; Tovi F; Sidi J; Zirkin H; Le Roith D
Isr J Med Sci; 1979 Feb; 15(2):151-5. PubMed ID: 468523
[TBL] [Abstract][Full Text] [Related]
35. Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times.
Laure Giraudet A; Al Ghulzan A; Aupérin A; Leboulleux S; Chehboun A; Troalen F; Dromain C; Lumbroso J; Baudin E; Schlumberger M
Eur J Endocrinol; 2008 Feb; 158(2):239-46. PubMed ID: 18230832
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic values of carcinoembryonic antigen in medullary carcinoma of the thyroid.
Saad MF; Fritsche HA; Samaan NA
J Clin Endocrinol Metab; 1984 May; 58(5):889-94. PubMed ID: 6707192
[TBL] [Abstract][Full Text] [Related]
37. Small cell medullary thyroid carcinoma: A diagnostic dilemma.
Verma A; Kane S; Vinarkar S; D'Cruz AK
Indian J Pathol Microbiol; 2017; 60(4):562-564. PubMed ID: 29323074
[TBL] [Abstract][Full Text] [Related]
38. Human medullary thyroid carcinoma in tissue culture; secretion of calcitonin and carcinoembryonic antigen.
Oosterom R; Verleun T; Bruining HA; Hackeng WH; Lamberts SW
J Endocrinol Invest; 1987 Apr; 10(2):117-21. PubMed ID: 3035000
[TBL] [Abstract][Full Text] [Related]
39. Medullary thyroid carcinoma: importance of serial serum calcitonin measurement.
Stepanas AV; Samaan NA; Hill CS; Hickey RC
Cancer; 1979 Mar; 43(3):825-37. PubMed ID: 427724
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.
Raue F; Kotzerke J; Reinwein D; Schröder S; Röher HD; Deckart H; Höfer R; Ritter M; Seif F; Buhr H
Clin Investig; 1993 Jan; 71(1):7-12. PubMed ID: 8095831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]